FDA Clearance Tracker · P900030-S009
CONTIGEN BARD COLLAGEN IMPLANT
Last checked: Nov 20, 2026Latest source record: Sep 21, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Sep 21, 2006
Approved
Time to decision
465 days
Received Jun 13, 2005. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P900030-S009
- Device name
- CONTIGEN BARD COLLAGEN IMPLANT
- Applicant
- Allergan, Inc.
- Applicant location
- Goleta, CA
- Received
- Jun 13, 2005
- Decided
- Sep 21, 2006
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P900030
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR REVISED DIRECTIONS FOR USE (DFU) THAT INCLUDE INFORMATION FROM THE POST-APPROVAL STUDY ON COHORT B.
Source documents
Other decisions for Allergan, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K190674 · Decided Aug 8, 2019 · 146 days after receipt
Device type: Accessories, Soft Lens Products (LPN) · Ophthalmology
K161457 · Decided Nov 21, 2016 · 179 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
K143354 · Decided Aug 20, 2015 · 269 days after receipt
Device type: Tissue Expander And Accessories (LCJ) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.